1. Home
  2. VTGN vs SFHG Comparison

VTGN vs SFHG Comparison

Compare VTGN & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.21

Market Cap

9.5M

Sector

Health Care

ML Signal

HOLD

Logo Samfine Creation Holdings Group Limited Ordinary Share

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

SELL

Current Price

$2.06

Market Cap

9.5M

ML Signal

SELL

Company Overview

Basic Information
Metric
VTGN
SFHG
Founded
1998
1993
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
9.5M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
VTGN
SFHG
Price
$0.21
$2.06
Analyst Decision
Hold
Analyst Count
4
0
Target Price
★ $1.00
N/A
AVG Volume (30 Days)
★ 18.1M
8.2K
Earning Date
11-12-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
★ N/A
Revenue This Year
$33.96
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.20
$0.32
52 Week High
$5.14
$3.17

Technical Indicators

Market Signals
Indicator
VTGN
SFHG
Relative Strength Index (RSI) 38.52 43.07
Support Level N/A $2.06
Resistance Level $0.66 $2.56
Average True Range (ATR) 0.02 0.05
MACD -0.01 -0.00
Stochastic Oscillator 11.60 13.79

Price Performance

Historical Comparison
VTGN
SFHG

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: